How US-UK drug deal will benefit patients | Letters

Many new medicines have reached NHS patients as a result of the government’s reformed pricing arrangements, writes Richard Torbett . Plus a letter from Nick Hoile The suggestion that the US-UK pharmaceutical agreement will result in excess…